NON-EXCLUSIVE LICENSE AND MATERIAL TRANSFER AGREEMENTNon-Exclusive License and Material Transfer Agreement • May 4th, 2007 • Regeneron Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 4th, 2007 Company Industry JurisdictionThis Non-Exclusive License and Material Transfer Agreement (“Agreement”) is entered into with an effective date as of March 30, 2007 (the “Effective Date”), by and between Astellas Pharma Inc., a Japanese company with a principal place of business located at 2-3-11 Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8411, Japan (“Company”), and Regeneron Pharmaceuticals, Inc. (“Regeneron”), a New York corporation, with a principal place of business located at 777 Old Saw Mill River Road, Tarrytown, New York 10591-6707.
NON-EXCLUSIVE LICENSE AND MATERIAL TRANSFER AGREEMENTNon-Exclusive License and Material Transfer Agreement • April 17th, 2023 • New York
Contract Type FiledApril 17th, 2023 JurisdictionThis Non-Exclusive License and Material Transfer Agreement (“Agreement”) is entered into with an effective date as of March 30, 2007 (the “Effective Date”), by and between Astellas Pharma Inc., a Japanese company with a principal place of business located at 2-3-11 Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8411, Japan (“Company”), and Regeneron Pharmaceuticals, Inc. (“Regeneron”), a New York corporation, with a principal place of business located at 777 Old Saw Mill River Road, Tarrytown, New York 10591-6707.
WITNESSETHNon-Exclusive License and Material Transfer Agreement • March 12th, 2007 • Regeneron Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 12th, 2007 Company Industry Jurisdiction